Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis (original) (raw)

• Anstee, Q. M., McPherson, S. & Day, C. P. How big a problem is non-alcoholic fatty liver disease? BMJ 343, d3897 (2011).
  PubMed Google Scholar
• de Alwis, N. M. & Day, C. P. Non-alcoholic fatty liver disease: the mist gradually clears. J. Hepatol. 48 (Suppl. 1), S104–S112 (2008).
  Article CAS PubMed Google Scholar
• Sanyal, A. J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123, 1705–1725 (2002).
  Article PubMed Google Scholar
• Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372–384 (2010).
  PubMed Google Scholar
• Das, K. et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 51, 1593–1602 (2010).
  CAS PubMed Google Scholar
• Baumeister, S. E. et al. Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 134, 85–94 (2008).
  Article PubMed Google Scholar
• Charlton, M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin. Gastroenterol. Hepatol. 2, 1048–1058 (2004).
  Article PubMed Google Scholar
• Cobbold, J. F., Anstee, Q. M. & Taylor-Robinson, S. D. The importance of fatty liver disease in clinical practice. Proc. Nutr. Soc. 69, 518–527 (2010).
  Article CAS PubMed Google Scholar
• Musso, G., Gambino, R., Cassader, M. & Pagano, G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann. Med. 43, 617–649 (2011).
  Article PubMed Google Scholar
• Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898–1906 (2005).
  Article PubMed Google Scholar
• Argo, C. K. & Caldwell, S. H. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin. Liver Dis. 13, 511–531 (2009).
  Article PubMed Google Scholar
• Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005–2023 (2012).
  Article PubMed Google Scholar
• American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. Gastroenterology 123, 1364–1366 (2002).
• Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002).
  Article PubMed Google Scholar
• Schwenzer, N. F. et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 51, 433–445 (2009).
  Article PubMed Google Scholar
• Dasarathy, S. et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J. Hepatol. 51, 1061–1067 (2009).
  Article PubMed PubMed Central Google Scholar
• Thomas, E. L. et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54, 122–127 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Cobbold, J. F. et al. Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue. Clin. Sci. (Lond.) 116, 403–413 (2009).
  Article CAS Google Scholar
• Armstrong, M. J. et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J. Hepatol. 56, 234–240 (2012).
  Article PubMed Google Scholar
• Mofrad, P. et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37, 1286–1292 (2003).
  Article PubMed Google Scholar
• Vernon, G., Baranova, A. & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 34, 274–285 (2011).
  Article CAS PubMed Google Scholar
• Minervini, M. I. et al. Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J. Hepatol. 50, 501–510 (2009).
  Article PubMed Google Scholar
• Nadalin, S. et al. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl. 11, 980–986 (2005).
  Article PubMed Google Scholar
• Tran, T. T. et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J. Gastroenterol. Hepatol. 21, 381–383 (2006).
  Article PubMed Google Scholar
• Ryan, C. K., Johnson, L. A., Germin, B. I. & Marcos, A. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl. 8, 1114–1122 (2002).
  Article PubMed Google Scholar
• Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387–1395 (2004).
  Article PubMed Google Scholar
• Szczepaniak, L. S. et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462–E468 (2005).
  Article CAS PubMed Google Scholar
• Targher, G. et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30, 1212–1218 (2007).
  Article PubMed Google Scholar
• Jimba, S. et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet. Med. 22, 1141–1145 (2005).
  Article CAS PubMed Google Scholar
• Williams, C. D. et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140, 124–131 (2011).
  Article PubMed Google Scholar
• Williamson, R. M. et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 34, 1139–1144 (2011).
  Article PubMed PubMed Central Google Scholar
• Bellentani, S., Bedogni, G., Miglioli, L. & Tiribelli, C. The epidemiology of fatty liver. Eur. J. Gastroenterol. Hepatol. 16, 1087–1093 (2004).
  Article PubMed Google Scholar
• Wanless, I. R. & Lentz, J. S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12, 1106–1110 (1990).
  Article CAS PubMed Google Scholar
• Silverman, J. F., Pories, W. J. & Caro, J. F. Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol. Annu. 24, 275–302 (1989).
  PubMed Google Scholar
• Smith, B. W. & Adams, L. A. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat. Rev. Endocrinol. 7, 456–465 (2011).
  Article CAS PubMed Google Scholar
• Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917–923 (2003).
  Article PubMed Google Scholar
• Kotronen, A. & Yki-Jarvinen, H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28, 27–38 (2008).
  Article CAS PubMed Google Scholar
• Vanni, E. et al. From the metabolic syndrome to NAFLD or vice versa? Dig. Liver Dis. 42, 320–330 (2010).
  Article CAS PubMed Google Scholar
• Kotronen, A., Westerbacka, J., Bergholm, R., Pietilainen, K. H. & Yki-Jarvinen, H. Liver fat in the metabolic syndrome. J. Clin. Endocrinol. Metab. 92, 3490–3497 (2007).
  Article CAS PubMed Google Scholar
• Kotronen, A. et al. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 31, 165–169 (2008).
  Article CAS PubMed Google Scholar
• Ryysy, L. et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49, 749–758 (2000).
  Article CAS PubMed Google Scholar
• Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221–1231 (2002).
  Article CAS PubMed Google Scholar
• Adams, L. A. et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am. J. Gastroenterol. 105, 1567–1573 (2010).
  Article PubMed PubMed Central Google Scholar
• de Marco, R. et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22, 756–761 (1999).
  Article CAS PubMed Google Scholar
• Targher, G. et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 51, 444–450 (2008).
  Article CAS PubMed Google Scholar
• Targher, G. et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin. J. Am. Soc. Nephrol. 5, 2166–2171 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Targher, G. et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 53, 1341–1348 (2010).
  Article CAS PubMed Google Scholar
• Targher, G. Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer - a narrative review. Clin. Chem. Lab. Med. 48, 147–157 (2010).
  Article CAS PubMed Google Scholar
• Lee, D. H. et al. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Diabetologia 46, 359–364 (2003).
  Article CAS PubMed Google Scholar
• Hanley, A. J. G. et al. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54, 3140–3147 (2005).
  Article CAS PubMed Google Scholar
• Monami, M. et al. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 57, 387–392 (2008).
  Article CAS PubMed Google Scholar
• Goessling, W. et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135, 1935–1944 (2008).
  Article CAS PubMed Google Scholar
• Ford, E. S. et al. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 31, 1138–1143 (2008).
  Article PubMed Google Scholar
• Adams, L. A., Waters, O. R., Knuiman, M. W., Elliott, R. R. & Olynyk, J. K. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am. J. Gastroenterol. 104, 861–867 (2009).
  Article PubMed Google Scholar
• Fraser, A. et al. Alanine aminotransferase, γ-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 32, 741–750 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Okamoto, M. et al. The association of fatty liver and diabetes risk. J. Epidemiol. 13, 15–21 (2003).
  Article PubMed Google Scholar
• Fan, J. G. et al. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol. 22, 1086–1091 (2007).
  Article CAS PubMed Google Scholar
• Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M. & Otsuki, M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30, 2940–2944 (2007).
  Article CAS PubMed Google Scholar
• Kim, C. H., Park, J. Y., Lee, K. U., Kim, J. H. & Kim, H. K. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet. Med. 25, 476–481 (2008).
  Article CAS PubMed Google Scholar
• Yamada, T. et al. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J. Gastroenterol. Hepatol. 25, 352–356 (2010).
  Article CAS PubMed Google Scholar
• Sung, K. C. & Kim, S. H. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J. Clin. Endocrinol. Metab. 96, 1093–1097 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bae, J. C. et al. Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study. Diabetes Care 34, 727–729 (2011).
  Article PubMed PubMed Central Google Scholar
• Sung, K. C., Jeong, W. S., Wild, S. H. & Byrne, C. D. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. Diabetes Care 35, 717–722 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865–873 (2006).
  Article CAS PubMed Google Scholar
• Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341–1350 (2010).
  Article CAS PubMed Google Scholar
• Bhatia, L. S., Curzen, N. P., Calder, P. C. & Byrne, C. D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J. 33, 1190–1200 (2012).
  Article CAS PubMed Google Scholar
• Targher, G., Chonchol, M., Zoppini, G., Abaterusso, C. & Bonora, E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J. Hepatol. 54, 1020–1029 (2011).
  Article CAS PubMed Google Scholar
• Li, Y., Xu, C., Yu, C., Xu, L. & Miao, M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J. Hepatol. 50, 1029–1034 (2009).
  Article CAS PubMed Google Scholar
• Sirota, J. C. et al. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 62, 392–399 (2013).
  Article CAS PubMed Google Scholar
• Petta, S., Camma, C., Cabibi, D., Di Marco, V. & Craxi, A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 34, 757–766 (2011).
  Article CAS PubMed Google Scholar
• Targher, G. et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 17, 517–524 (2007).
  Article CAS PubMed Google Scholar
• Hui, J. M., Farrell, G. C., Kench, J. G. & George, J. High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD. Hepatology 39, 1458–1459 (2004).
  Article PubMed Google Scholar
• Targher, G. et al. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 64, 679–683 (2006).
  Article CAS Google Scholar
• Bugianesi, E. et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J. Clin. Endocrinol. Metab. 90, 3498–3504 (2005).
  Article CAS PubMed Google Scholar
• Targher, G. et al. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin. Thromb. Hemost. 35, 277–287 (2009).
  Article CAS PubMed Google Scholar
• Northup, P. G., Argo, C. K., Shah, N. & Caldwell, S. H. Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications. Semin. Liver Dis. 32, 39–48 (2012).
  Article CAS PubMed Google Scholar
• Sookoian, S. et al. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. Atherosclerosis 209, 585–591 (2010).
  Article CAS PubMed Google Scholar
• Wieckowska, A. et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103, 1372–1379 (2008).
  Article CAS PubMed Google Scholar
• Sookoian, S. et al. Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. Atherosclerosis 218, 378–385 (2011).
  Article CAS PubMed Google Scholar
• Greco, D. et al. Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1281–G1287 (2008).
  Article CAS PubMed Google Scholar
• Westerbacka, J. et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56, 2759–2765 (2007).
  Article CAS PubMed Google Scholar
• Villanova, N. et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42, 473–480 (2005).
  Article PubMed Google Scholar
• Pacifico, L. et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 52, 1643–1651 (2010).
  Article PubMed Google Scholar
• Salvi, P. et al. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study. J. Hypertens. 28, 1699–1707 (2010).
  Article CAS PubMed Google Scholar
• Lee, Y.-J. et al. The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig. Dis. Sci. 57, 196–203 (2012).
  Article CAS PubMed Google Scholar
• Targher, G. et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 27, 2498–2500 (2004).
  Article PubMed Google Scholar
• Brea, A. et al. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler. Thromb. Vasc. Biol. 25, 1045–1050 (2005).
  Article CAS PubMed Google Scholar
• Volzke, H. et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J. Gastroenterol. 11, 1848–1853 (2005).
  Article PubMed PubMed Central Google Scholar
• Fracanzani, A. L. et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am. J. Med. 121, 72–78 (2008).
  Article PubMed Google Scholar
• Kozakova, M. et al. Fatty liver index, γ-glutamyltransferase, and early carotid plaques. Hepatology 55, 1406–1415 (2012).
  Article CAS PubMed Google Scholar
• Sookoian, S. & Pirola, C. J. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J. Hepatol. 49, 600–607 (2008).
  Article PubMed Google Scholar
• Targher, G. et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29, 1325–1330 (2006).
  Article PubMed Google Scholar
• Colak, Y. et al. Assessment of endothelial function in patients with nonalcoholic fatty liver disease. Endocrine 43, 100–107 (2013).
  Article CAS PubMed Google Scholar
• Sung, K. C., Wild, S. H., Kwag, H. J. & Byrne, C. D. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care 35, 2359–2364 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Goland, S. et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J. Clin. Gastroenterol. 40, 949–955 (2006).
  Article PubMed Google Scholar
• Fallo, F. et al. Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. Nutr. Metab. Cardiovasc. Dis. 19, 646–653 (2009).
  Article CAS PubMed Google Scholar
• Bonapace, S. et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 35, 389–395 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Hallsworth, K. et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. J. Hepatol. http://dx.doi.org/10.1016/j.jhep.2012.11.015.
• Perseghin, G. et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 47, 51–58 (2008).
  Article CAS PubMed Google Scholar
• Rijzewijk, L. J. et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J. Am. Coll. Cardiol. 56, 225–233 (2010).
  Article CAS PubMed Google Scholar
• Lautamaki, R. et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 291, E282–E290 (2006).
  Article CAS PubMed Google Scholar
• Stepanova, M. & Younossi, Z. M. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin. Gastroenterol. Hepatol. 10, 646–650 (2012).
  Article PubMed Google Scholar
• Lazo, M. et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 343, d6891 (2011).
  Article PubMed PubMed Central Google Scholar
• Lin, Y. C., Lo, H. M. & Chen, J. D. Sonographic fatty liver, overweight and ischemic heart disease. World J. Gastroenterol. 11, 4838–4842 (2005).
  Article PubMed PubMed Central Google Scholar
• Targher, G. et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J. Hepatol. 53, 713–718 (2010).
  Article CAS PubMed Google Scholar
• Mirbagheri, S. A., Rashidi, A., Abdi, S., Saedi, D. & Abouzari, M. Liver: an alarm for the heart? Liver Int. 27, 891–894 (2007).
  Article PubMed Google Scholar
• Assy, N., Djibre, A., Farah, R., Grosovski, M. & Marmor, A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 254, 393–400 (2010).
  Article PubMed Google Scholar
• Wong, V. W. et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60, 1721–1727 (2011).
  Article CAS PubMed Google Scholar
• Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413–1419 (1999).
  Article CAS PubMed Google Scholar
• Dam-Larsen, S. et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53, 750–755 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Rafiq, N. et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 7, 234–238 (2009).
  Article PubMed Google Scholar
• Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113–121 (2005).
  Article PubMed Google Scholar
• Soderberg, C. et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 51, 595–602 (2010).
  Article PubMed Google Scholar
• Jepsen, P., Vilstrup, H., Moller, J. K. & Sorensen, H. T. Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis. Hepatogastroenterology 50, 2133–2136 (2003).
  PubMed Google Scholar
• Hamaguchi, M. et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J. Gastroenterol. 13, 1579–1584 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Targher, G. et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 30, 2119–2121 (2007).
  Article CAS PubMed Google Scholar
• Haring, R. et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum γ-glutamyl transpeptidase levels. Hepatology 50, 1403–1411 (2009).
  Article PubMed Google Scholar
• Zhou, Y. J., Li, Y. Y., Nie, Y. Q., Huang, C. M. & Cao, C. Y. Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. J. Dig. Dis. 13, 153–160 (2012).
  Article PubMed Google Scholar
• Fraser, A. et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler. Thromb. Vasc. Biol. 27, 2729–2735 (2007).
  Article CAS PubMed Google Scholar
• Treeprasertsuk, S. et al. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int. 32, 945–950 (2012).
  Article PubMed PubMed Central Google Scholar
• Powell, E. E. et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 74–80 (1990).
  Article PubMed Google Scholar
• Ratziu, V. et al. Liver fibrosis in overweight patients. Gastroenterology 118, 1117–1123 (2000).
  Article CAS PubMed Google Scholar
• Harrison, S. A., Torgerson, S. & Hayashi, P. H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am. J. Gastroenterol. 98, 2042–2047 (2003).
  Article PubMed Google Scholar
• Evans, C. D., Oien, K. A., MacSween, R. N. & Mills, P. R. Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J. Clin. Pathol. 55, 689–692 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Adams, L. A., Sanderson, S., Lindor, K. D. & Angulo, P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol. 42, 132–138 (2005).
  Article PubMed Google Scholar
• Lee, R. G. Nonalcoholic steatohepatitis: a study of 49 patients. Hum. Pathol. 20, 594–598 (1989).
  Article CAS PubMed Google Scholar
• Bacon, B. R., Farahvash, M. J., Janney, C. G. & Neuschwander-Tetri, B. A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107, 1103–1109 (1994).
  Article CAS PubMed Google Scholar
• Fassio, E., Alvarez, E., Dominguez, N., Landeira, G. & Longo, C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40, 820–826 (2004).
  PubMed Google Scholar
• Caldwell, S. H. et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29, 664–669 (1999).
  Article CAS PubMed Google Scholar
• Poonawala, A., Nair, S. P. & Thuluvath, P. J. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32, 689–692 (2000).
  Article CAS PubMed Google Scholar
• Porepa, L., Ray, J. G., Sanchez-Romeu, P. & Booth, G. L. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 182, 526–531 (2010).
  Article Google Scholar
• Sanyal, A., Poklepovic, A., Moyneur, E. & Barghout, V. Population-based risk factors and resource utilization for HCC: US perspective. Curr. Med. Res. Opin. 26, 2183–2191 (2010).
  Article CAS PubMed Google Scholar
• Parkin, D. M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030–3044 (2006).
  Article CAS PubMed Google Scholar
• Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51, 1820–1832 (2010).
  Article PubMed Google Scholar
• Hashimoto, E. et al. Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J. Gastroenterol. 44 (Suppl. 19), 89–95 (2009).
  Article PubMed Google Scholar
• Ascha, M. S. et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51, 1972–1978 (2010).
  Article PubMed Google Scholar
• El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557–2576 (2007).
  Article CAS PubMed Google Scholar
• Calle, E. E., Rodriguez, C., Walker-Thurmond, K. & Thun, M. J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N. Engl. J. Med. 348, 1625–1638 (2003).
  PubMed Google Scholar
• Moller, H., Mellemgaard, A., Lindvig, K. & Olsen, J. H. Obesity and cancer risk: a Danish record-linkage study. Eur. J. Cancer 30A, 344–350 (1994).
  Article CAS PubMed Google Scholar
• Oh, S. W., Yoon, Y. S. & Shin, S. A. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J. Clin. Oncol. 23, 4742–4754 (2005).
  Article PubMed Google Scholar
• El-Serag, H. B., Tran, T. & Everhart, J. E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126, 460–468 (2004).
  Article PubMed Google Scholar
• Guzman, G. et al. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch. Pathol. Lab. Med. 132, 1761–1766 (2008).
  PubMed Google Scholar
• Bonora, E. & Targher, G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 9, 372–381 (2012).
  Article CAS PubMed Google Scholar
• Ix, J. H. & Sharma, K. Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. J. Am. Soc. Nephrol. 21, 406–412 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Yki-Jarvinen, H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig. Dis. 28, 203–209 (2010).
  Article CAS PubMed Google Scholar
• Badman, M. K. & Flier, J. S. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 132, 2103–2115 (2007).
  Article CAS PubMed Google Scholar
• Shoelson, S. E., Herrero, L. & Naaz, A. Obesity, inflammation, and insulin resistance. Gastroenterology 132, 2169–2180 (2007).
  Article CAS PubMed Google Scholar
• Stefan, N., Kantartzis, K. & Haring, H.-U. Causes and metabolic consequences of fatty liver. Endocr. Rev. 29, 939–960 (2008).
  Article CAS PubMed Google Scholar
• Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679–689 (2010).
  Article CAS PubMed Google Scholar
• Tilg, H. & Moschen, A. R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 19, 371–379 (2008).
  Article CAS PubMed Google Scholar
• Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343–1351 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Yamaguchi, K. et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45, 1366–1374 (2007).
  Article CAS PubMed Google Scholar
• Malhi, H., Gores, G. J. & Lemasters, J. J. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43, S31–S44 (2006).
  Article CAS PubMed Google Scholar
• Anstee, Q. M. et al. Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. J. Hepatol. 53, 542–550 (2010).
  Article CAS PubMed Google Scholar
• Farrell, G. C. et al. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. J. Gastroenterol. Hepatol. 24, 443–452 (2009).
  Article CAS PubMed Google Scholar
• Iredale, J. P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117, 539–548 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Anstee, Q. M., Daly, A. K. & Day, C. P. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin. Liver Dis. 31, 128–146 (2011).
  Article CAS PubMed Google Scholar
• Anstee, Q. M. & Goldin, R. D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87, 1–16 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• McCarthy, M. I. & Zeggini, E. Genome-wide association studies in type 2 diabetes. Curr. Diab. Rep. 9, 164–171 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Anstee, Q. M., Daly, A. K. & Day, C. P. Genetic modifiers of non-alcoholic fatty liver disease progression. Biochim. Biophysica Acta 1812, 1557–1566 (2011).
  Article CAS Google Scholar
• Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461–1465 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 139, 1567–1576 (2010).
  Article PubMed Google Scholar
• Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Anstee, Q. M. et al. Genome-wide association analysis confirms importance of PNPLA3 and identifies novel variants associated with histologically progressive fibrosing steatohepatitis in NAFLD [abstract 146]. Hepatology 56 (Suppl.), 265A–266A (2012).
  Google Scholar
• Kawaguchi, T. et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS ONE 7, e38322 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209–1217 (2010).
  Article CAS PubMed Google Scholar
• Kotronen, A. et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52, 1056–1060 (2009).
  Article CAS PubMed Google Scholar
• Sookoian, S. et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J. Lipid Res. 50, 2111–2116 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Kantartzis, K. et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58, 2616–2623 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E. & Liang, T. J. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 52, 894–903 (2010).
  Article CAS PubMed Google Scholar
• Namikawa, C. et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 40, 781–786 (2004).
  Article CAS PubMed Google Scholar
• Al-Serri, A. et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J. Hepatol. 56, 448–454 (2012).
  Article CAS PubMed Google Scholar
• Dong, H. et al. The phosphatidylethanolamine N-methyltransferase gene V175M single nucleotide polymorphism confers the susceptibility to NASH in Japanese population. J. Hepatol. 46, 915–920 (2007).
  Article CAS PubMed Google Scholar
• Song, J. et al. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). Faseb J. 19, 1266–1271 (2005).
  Article CAS PubMed Google Scholar
• Narla, G. et al. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res. 65, 1213–1222 (2005).
  Article CAS PubMed Google Scholar
• Miele, L. et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 135, 282–291 (2008).
  Article CAS PubMed Google Scholar
• Romeo, S., Huang-Doran, I., Baroni, M. G. & Kotronen, A. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Curr. Opin. Lipidol. 21, 247–252 (2010).
  Article CAS PubMed Google Scholar
• Zimmermann, R. et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383–1386 (2004).
  Article CAS PubMed Google Scholar
• Kollerits, B. et al. A common variant in the adiponutrin gene influences liver enzyme values. J. Med. Genet. 47, 116–119 (2010).
  Article CAS PubMed Google Scholar
• Li, J. Z. et al. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. J. Clin. Invest. 122, 4130–4144 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Thoma, C., Day, C. P. & Trenell, M. I. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J. Hepatol. 56, 255–266 (2012).
  Article PubMed Google Scholar
• Hallsworth, K. et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60, 1278–1283 (2011).
  Article PubMed Google Scholar
• Kerr, T. A. & Davidson, N. O. Cholesterol and nonalcoholic fatty liver disease: Renewed focus on an old villain. Hepatology 56, 1995–1998 (2012).
  Article PubMed Google Scholar
• Ouyang, X. et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 48, 993–999 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J. M. & Lustig, R. H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7, 251–264 (2010).
  Article CAS PubMed Google Scholar
• Abdelmalek, M. F. et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961–1971 (2010).
  Article CAS PubMed Google Scholar
• Bergheim, I. et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48, 983–992 (2008).
  Article CAS PubMed Google Scholar
• Rivera, C. A. et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 47, 571–579 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Spruss, A. et al. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50, 1094–1104 (2009).
  Article CAS PubMed Google Scholar
• Payne, J. H., Dewind, L. T. & Commons, R. R. Metabolic observations in patients with jejunocolic shunts. Am. J. Surg. 106, 273–289 (1963).
  Article CAS PubMed Google Scholar
• Catlin, R. Liver dysfunction after intestinal bypass. JAMA 236, 1693–1694 (1976).
  Article CAS PubMed Google Scholar
• Wigg, A. J. et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48, 206–211 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Miele, L. et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877–1887 (2009).
  Article CAS PubMed Google Scholar
• Harte, A. L. et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J. Inflamm. (Lond.) 7, 15 (2010).
  Article CAS Google Scholar
• Weinstock, G. M. Genomic approaches to studying the human microbiota. Nature 489, 250–256 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Abu-Shanab, A. & Quigley, E. M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 7, 691–701 (2010).
  Article PubMed Google Scholar
• Tremaroli, V. & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242–249 (2012).
  Article CAS PubMed Google Scholar
• Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Musso, G. et al. Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. Hepatology 47, 1167–1177 (2008).
  Article CAS PubMed Google Scholar
• Kotronen, A. et al. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur. J. Endocrinol. 160, 593–602 (2009).
  Article CAS PubMed Google Scholar
• Yoneda, M. et al. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int. 29, 1078–1085 (2009).
  Article CAS PubMed Google Scholar
• Dixon, J. B. et al. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J. Hepatol. 39, 967–971 (2003).
  Article CAS PubMed Google Scholar
• Petersen, K. F. et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 362, 1082–1089 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Valenti, L. et al. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage in patients with nonalcoholic fatty liver. J. Hepatol. 55, 1409–1414 (2012).
  Article CAS Google Scholar
• Sazci, A. et al. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig. Dis. Sci. 53, 3218–3224 (2008).
  Article CAS PubMed Google Scholar
• Demirag, M. D. et al. Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease. Dig. Dis. Sci. 52, 3399–3403 (2007).
  Article CAS PubMed Google Scholar
• Sookoian, S., Castano, G., Gianotti, T. F., Gemma, C. & Pirola, C. J. Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease. J. Nutr. Biochem. 20, 765–770 (2009).
  Article CAS PubMed Google Scholar
• Day, C. P., Leathart, J., McTernan, P., Mathew, C. & Daly, A. Genetic evidence for a role of gut flora in the pathogenesis of NASH in humans. Hepatology 44 (Suppl. 1), 261A (2006).
  Google Scholar
• Dongiovanni, P. et al. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut 59, 267–273 (2010).
  Article CAS PubMed Google Scholar
• Carulli, L. et al. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis. Dig. Liver Dis. 41, 823–828 (2009).
  Article CAS PubMed Google Scholar
• Oliveira, C. P. et al. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 25, 357–361 (2010).
  Article CAS PubMed Google Scholar
• George, D. K. et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114, 311–318 (1998).
  Article CAS PubMed Google Scholar
• Nelson, J. E. et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 46, 723–729 (2007).
  Article CAS PubMed Google Scholar
• Bugianesi, E. et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39, 179–187 (2004).
  Article CAS PubMed Google Scholar
• Nobili, V., Daly, A. K., Al-Serri, A., Leathart, J. B. & Day, C. P. The mitochondrial superoxide dismutase 2 (SOD2) targeting sequence polymorphism is associated with fibrotic NAFLD: consistent evidence from case-control and intra-familial allelic association studies. Hepatology 46, 760A (2007).
  Google Scholar
• Sazci, A. et al. Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH). Cell Biochem. Funct. 26, 291–296 (2008).
  Article CAS PubMed Google Scholar
• Sookoian, S. et al. The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet. Genomics 20, 1–8 (2010).
  Article CAS PubMed Google Scholar
• Musso, G. et al. Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology 49, 426–435 (2009).
  Article CAS PubMed Google Scholar
• Valenti, L. et al. Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122, 274–280 (2002).
  Article CAS PubMed Google Scholar